Bruker (BRKR) Receivables (2010 - 2026)

Bruker (BRKR) has reported Receivables for 17 consecutive years, with $661.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 4.24% year-over-year to $661.9 million; the trailing twelve-month figure through Jun 2026 stood at $661.9 million (up 4.24% YoY), and the FY2025 full-year result was $657.4 million, changed 0.26% from the prior year.
• Receivables held at $661.9 million in Q2 2026 per BRKR's latest filing, from $660.9 million in the prior quarter.
• Across five years, Receivables topped out at $669.5 million in Q3 2025 and bottomed at $402.6 million in Q2 2022.
• Historically, Receivables has averaged $573.1 million across 5 years, with a median of $590.8 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Receivables jumped 36.22% in 2023, then slipped 0.26% in 2025.
• Over 5 years, Receivables stood at $533.5 million in 2022, then gained by 7.7% to $574.6 million in 2023, then increased by 14.71% to $659.1 million in 2024, then declined by 0.26% to $657.4 million in 2025, then increased by 0.68% to $661.9 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $661.9 million, $660.9 million, and $657.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.